Beijing Dongfang Biotech Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Beijing China (2006)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT02971722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beijing Dongfang Biotech Co., Ltd.